A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability
about
How drugs get into cells: tested and testable predictions to help discriminate between transporter-mediated uptake and lipoidal bilayer diffusionFast disintegrating tablets: Opportunity in drug delivery systemVeterinary Medicine Needs New Green Antimicrobial DrugsNanostructured lipid carriers: An emerging platform for improving oral bioavailability of lipophilic drugsPolymorph Impact on the Bioavailability and Stability of Poorly Soluble DrugsNanotechnology-based drug delivery systems for the treatment of Alzheimer's diseaseDrug Delivery Approaches in Addressing Clinical Pharmacology-Related Issues: Opportunities and ChallengesA Critical Appraisal of Solubility Enhancement Techniques of PolyphenolsDarunavir: a critical review of its properties, use and drug interactionsTranslating Human Effective Jejunal Intestinal Permeability to Surface-Dependent Intrinsic Permeability: a Pragmatic Method for a More Mechanistic Prediction of Regional Oral Drug Absorption.Physiological parameters for oral delivery and in vitro testingDrug transporters in tissues and cells relevant to sexual transmission of HIV: Implications for drug deliveryPharmacokinetic aspects and in vitro-in vivo correlation potential for lipid-based formulationsIron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseasesPharmaceutical Cocrystals: Regulatory and Strategic Aspects, Design and DevelopmentOral delivery of lipophilic drugs: the tradeoff between solubility increase and permeability decrease when using cyclodextrin-based formulationsIdentification of Selective Inhibitors of the Plasmodium falciparum Hexose Transporter PfHT by Screening Focused Libraries of Anti-Malarial CompoundsAssessment of Efficacy and Quality of Two Albendazole Brands Commonly Used against Soil-Transmitted Helminth Infections in School Children in Jimma Town, EthiopiaRelease of a Poorly Soluble Drug from Hydrophobically Modified Poly (Acrylic Acid) in Simulated Intestinal FluidsA Novel Diphenylthiosemicarbazide Is a Potential Insulin Secretagogue for Anti-Diabetic AgenMembrane transporters in drug developmentFabrication of carvedilol nanosuspensions through the anti-solvent precipitation-ultrasonication method for the improvement of dissolution rate and oral bioavailability.Case studies for practical food effect assessments across BCS/BDDCS class compounds using in silico, in vitro, and preclinical in vivo data.Development and validation of a dissolution test for lodenafil carbonate based on in vivo data.The use of ROC analysis for the qualitative prediction of human oral bioavailability from animal data.Gemifloxacin mesylate (GFM): dissolution test based on in vivo data.In silico predictions of drug solubility and permeability: two rate-limiting barriers to oral drug absorption.Particle size reduction for improvement of oral absorption of the poorly soluble drug UG558 in rats during early development.Valproic acid-hydrophilic cyclodextrin complexes and valproic acid-solid dispersions: evaluation of their potential pharmaceutical use.Development of In Vitro-In Vivo Correlation/Relationship Modeling Approaches for Immediate Release Formulations Using Compartmental Dynamic Dissolution Data from "Golem": A Novel Apparatus.Improved oral absorption of cilostazol via sulfonate salt formation with mesylate and besylateMechanistic insight into the dramatic improvement of probucol dissolution in neutral solutions by solid dispersion in Eudragit E PO with saccharin.Supramolecular Complex of Ibuprofen with Larch Polysaccharide Arabinogalactan: Studies on Bioavailability and Pharmacokinetics.Characterization of the bulk properties of pharmaceutical solids using nonlinear optics--a review.The effect of food on the bioavailability of panobinostat, an orally active pan-histone deacetylase inhibitor, in patients with advanced cancer.Practical anticipation of human efficacious doses and pharmacokinetics using in vitro and preclinical in vivo data.Influence of formulation factors on tablet formulations with liquid permeation enhancer using factorial design.Effect of cyclodextrin complexation on the aqueous solubility and solubility/dose ratio of praziquantel.Enhanced oral bioavailability of valsartan using a polymer-based supersaturable self-microemulsifying drug delivery system.Effect of lipolysis on drug release from self-microemulsifying drug delivery systems (SMEDDS) with different core/shell drug location.
P2860
Q24273350-14594320-B383-4267-88EC-061ACEECC50AQ24612643-450FEDCE-C0DD-4C97-BC4E-F0E67DB2C9BCQ26740600-E454BC4A-83A3-4964-9C51-1FFCA1EC74BEQ26774831-EF0A388D-C9EE-4C37-B2E1-BE11B0435B4BQ26779030-FB03E674-6E5D-4492-94ED-FE075F839200Q26783306-0F03CBFF-1768-4AF0-9D34-462117947A11Q26798105-38CBA339-01E2-4F08-A26D-BE4884453E3FQ26852410-D49AEC37-A8C8-4C7D-BF49-406D8996791CQ26998856-634B35FC-E2F1-4A45-B462-81B76D40282FQ27313187-D7E97F06-E0BD-4975-AE8C-0672510D26B9Q27687044-25435EF8-0BB1-49EA-8C89-ADA2C350A883Q28081272-E0E06AB0-1340-4D70-9EE0-44DFF76D67B4Q28084784-16D45F5C-E9DA-4DD4-9BAD-26F899EB4A7DQ28388335-62233FF9-42B0-4882-9D81-8735721BD1CAQ28468556-F0D1BF72-AF6F-43FA-8745-A3422445565BQ28534686-18F32113-002F-46BD-B80F-12EB230D88D1Q28546576-ECE0205D-8B14-4FD7-9763-FAD4612382E6Q28548540-699130B4-5A34-4EA4-8290-FE0B40F987B7Q28550369-E93146BF-186C-4DFD-B052-B189390D65D1Q28552837-41AC5B73-E0E8-49C5-A34E-A7BB4FB54802Q29616802-525714E3-944A-4242-8C67-0AE8983DB10BQ30459146-3A7473CB-0ADD-48CB-A207-B8585875DA58Q30576914-C41D919C-91A7-48D0-8E3A-14A9738A46E1Q30619752-5BEC3A14-C819-4BD5-B113-85942788D587Q30670381-576AEDC9-7E87-4F60-ADD0-A1547419ADF0Q30755146-745F7F16-7009-4A97-9521-1342E91EF8A8Q30847239-3C733BDC-5925-4DEF-BAE7-9553B489AE42Q30903645-716E28D7-E5F5-48BF-BD06-B9305D26DB00Q30909831-38BD9571-99A0-47D4-AC56-A2F73D4A9589Q30977297-CA61213B-DDC5-4B59-A5ED-2259F0DB2D50Q30985734-B77CA58C-68C6-4571-AB9D-8EF3074D1E59Q30987265-8FFC5885-A41B-405B-9FCF-68A54BAED6A3Q31111091-BDA0E366-A2DA-4D7B-BA33-576560D20086Q33271480-103373DF-A0F8-4E73-B580-43696667AE34Q33398014-BB887047-CA41-4B3F-8957-8D38ADAAE8DAQ33496817-0479CE01-27B8-4237-9A5C-0E944E955698Q33563604-68838978-DE1C-4231-AF95-7739C1DC6329Q33563610-33058D01-1381-4F51-8C81-0F2CC9AADDE3Q33674114-D13AE37F-35C3-40F0-8E8B-75CFD9EF5F30Q33681221-55AA0722-AD2B-44B2-A153-D9BB461079B6
P2860
A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability
description
1995 nî lūn-bûn
@nan
1995 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի մարտին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
A theoretical basis for a biop ...... on and in vivo bioavailability
@ast
A theoretical basis for a biop ...... on and in vivo bioavailability
@en
A theoretical basis for a biop ...... on and in vivo bioavailability
@nl
type
label
A theoretical basis for a biop ...... on and in vivo bioavailability
@ast
A theoretical basis for a biop ...... on and in vivo bioavailability
@en
A theoretical basis for a biop ...... on and in vivo bioavailability
@nl
prefLabel
A theoretical basis for a biop ...... on and in vivo bioavailability
@ast
A theoretical basis for a biop ...... on and in vivo bioavailability
@en
A theoretical basis for a biop ...... on and in vivo bioavailability
@nl
P2093
P3181
P356
P1476
A theoretical basis for a biop ...... on and in vivo bioavailability
@en
P2093
G L Amidon
H Lennernäs
J R Crison
P304
P3181
P356
10.1023/A:1016212804288
P407
P577
1995-03-01T00:00:00Z